<DOC>
	<DOCNO>NCT02686918</DOCNO>
	<brief_summary>The main study assess feasibility patient follow-up visit receive trastuzumab subcutaneous Advanced Practice Nurse .</brief_summary>
	<brief_title>Feasibility Assessment Patients Follow-up Visit Receiving Trastuzumab Subcutaneous Advanced Practice Nurse</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Patient care Cancer Institute Lucien Neuwirth Patient age 18 year Patient breast cancer overexpressing HER2 adjuvant Patient finish chemotherapy treatment IV follow oncologist day hospital Patient Trastzumab subcutaneously Patient affiliate entitle social security scheme ( mandatory requirement study ) Refusal participate , patient protect guardianship . Patient inability understand course study Patient document history cognitive psychiatric disorder . Patients pregnant lactate Patients guardianship curatorship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>